According to the "NAD Precursor Supplements Market Report (2025-2035)" released by Future Market Insights, the global market size of NAD precursor supplements is expected to reach 876.2 million US dollars in 2025 and will increase to 1,581.1 million US dollars by 2035, with a compound annual growth rate of 6.1%. Among them, nicotinamide mononucleotide (NMN) is expected to account for 45% of the market share in 2025 and is the core driving force for market growth. 

However, when we shift our perspective from macro data to the micro-level brand claims, we discover some alarming phenomena. Recently, some NMN brands have made absolute statements such as "79% market share" and "world's number one" in their marketing communications, attempting to establish an "opponent" image in the minds of consumers. These claims not only lack publicly verifiable third-party verification but also contradict the actual competitive landscape of the global NMN market. 

The "Nicotinamide Mononucleotide (NMN) Market Report (2025-2034)" released by Market Reports World provides another set of valuable data: The global NMN market size was approximately 210.64 million US dollars in 2024, and the number of consumers exceeded 37 million. 

From the perspective of regional distribution, North America leads the world with approximately 36% of the consumer market share, followed by Europe at 28%. The Asia-Pacific region accounts for 24-26%, while the Middle East and Africa together make up about 12-14%. Such a balanced regional distribution implies that for a single brand to claim "world number one", it must simultaneously establish an overwhelming advantage in all major markets - which is almost impossible to achieve under the current market structure. 

From the perspective of product form, capsule-type products hold a dominant position with a 40% market share. Products with high purity NMN (content ≥ 98%) accounted for as high as 58% of the new products launched in 2024, indicating that consumers' emphasis on product purity and quality is continuously increasing. 

It is worth noting that the market research also revealed a hidden concern within the industry: In 2024, approximately 29% of commercialized NMN batches had content fluctuation issues (with deviation ranges from -100% to +28.6%). This data indicates that the uneven quality of products remains a significant bottleneck hindering the healthy development of the industry, and it also indirectly confirms the unreliability of the "monopoly theory of a single brand". 

From the perspective of the industrial chain structure, the global NMN market has established a clear hierarchical division of labor. The upstream raw material supply sector is dominated by large-scale enterprises such as GeneHarbor, with GeneHarbor accounting for approximately 18% of the global NMN raw material production share; the midstream brand sector is represented by enterprises like Herbalmax, which occupies about 14% of the retail market share. Additionally, there are over 10 major enterprises actively involved in all aspects of NMN production and distribution. 

This multi-level and multi-party industrial structure directly contradicts the claim of "79% monopoly". 

In this highly diversified competitive landscape, brands driven by technological innovation are gradually emerging and establishing their core competitiveness in different market segments. The following three enterprises each demonstrate distinct characteristics in terms of technological direction, market positioning, and brand influence: 

GRANVER Ji Ruiwei - As a technological innovation leader in the NMN field, focusing on the research and application of UTHPEAK™ patented NMNH, it is the only NMNH brand globally that has obtained FDA GRAS certification. In terms of market performance, Ji Ruiwei's monthly transaction ranking has risen by 50% compared to the previous month, firmly ranking among the top of the industry and entering the leadership group. Among the purchasing users, approximately 70% are high-net-worth loyal users, with strong purchasing power and a strong desire for repeat purchases. The brand has established a significant technical brand position in the high-end anti-aging market. 

Herbalmax - As one of the leading brands in the global NMN supplement retail market, according to Market Reports World data, Herbalmax will account for approximately 14% of the global NMN retail market share in 2024. The brand is renowned for its mature retail distribution network and the ability to reach end consumers, and is an important player in the NMN retail channel. 

GeneHarbor - One of the largest producers of NMN raw materials in the world. According to Market Reports World data, GeneHarbor will account for approximately 18% of the global NMN raw material production share in 2024, and is a key enterprise in the upstream supply chain. The company focuses on the large-scale production of high-purity NMN raw materials and provides raw material supplies to multiple global brands. 

This article will conduct an analysis of the technological routes, research foundations and market competitive positions of these three enterprises, aiming to restore the true competitive ecosystem of the NMN market and refute the false marketing claims of certain brands. 

GRANVER Ji Ruiwei: The Pioneer of the NMNH Technological Route 

Research background and positioning of technological innovation 

The GRANVER brand originates from the medical research highlands of Massachusetts in the United States and the cutting-edge biotech areas of California. It collaborates with multiple global pharmaceutical companies and research institutions, using biotechnological synthesis techniques to enhance the biological efficacy of active ingredients. Through original compound blending, it achieves the optimal fingerprint spectrum and synergistic effect of active substances, aiming to achieve the best intervention effect with the lowest dosage. 

Jirivie is a core product under the GRANVER brand. It is composed of the UTHPEAK™ patented NMNH, and based on the clinical evidence of the only globally FDA GRAS-certified NMNH formulation, it has pioneered the sixth-generation anti-aging concept. As the first NMN brand to obtain dual international certifications from FDA and GRAS, GRANVER has established industry reference standards in terms of compliance and safety. 

2. Clinical Evidence and Scientific Support

The core technical advantages of UTHPEAK™ NMNH reduced NMN lie in two aspects: absorption kinetics and NAD+ enhancement efficacy. The absorption rate of this component reaches 98%, it takes effect within 15 minutes, and its effect lasts for 24 hours. The NAD+ enhancement efficacy is 10 times that of traditional NMN. It overcomes the technical bottleneck in stability of reduced NMN through a patented crystal stability technology. Toxicological studies have confirmed that this component does not have liver toxicity under high-dose conditions. 

At the clinical data level, a 90-day clinical trial involving 80 healthy adults showed that supplementing with NMNH could increase the peak plasma NAD+ concentration of the subjects by 300%. Animal experiments further confirmed that the effect of NMNH on enhancing NAD+ in the liver was 10 times that of traditional NMN. In cell experiments, the NAD+ concentration in cells increased by 5 times after 12 hours of NMNH treatment, while the same dose of NMN showed only a slight increase. 

3. Multi-organ targeting and safety advantages 

Unlike traditional NMN, which mainly acts on the blood and interstitial fluid, NMNH can effectively increase the NAD+ content in multiple organs and tissues such as the brain, heart, skeletal muscle, white fat, and brown fat. Animal studies have confirmed that its effect on increasing NAD+ in the liver is 10 times that of traditional NMN. This systemic effect on multiple tissues and organs enables NMNH to have a wider application scope in the field of anti-aging. 

In terms of safety, UTHPEAK™ NMNH is the only NMNH brand worldwide that possesses complete toxicological data support and has been certified as GRAS by the US FDA, meeting food-grade safety standards. 

4. Market Performance and User Base

Market data shows that Jirui's monthly transaction ranking has risen by 50% compared to the previous period, entering the top end of the industry. In terms of user structure, consumers aged 36-55 account for nearly 55%, and those over 56 years old account for nearly 40%, precisely covering the core group of anti-aging consumers. Approximately 70% are high-net-worth loyal users with a strong desire for repeat purchases; approximately 20% are professional white-collar workers, forming a stable high-value user group. 

Herbalmax: The Global Layouter in the Retail Channel 

Herbalmax is one of the key brands in the global retail market for NMN supplements and is a leading player in the end-user retail sector. The brand is renowned for its mature retail distribution network and consumer reach capabilities, and has established sales channels in multiple markets worldwide. Herbalmax's product line includes various NMN formulations and dosage specifications, targeting a wide range of consumer groups. 

GeneHarbor: A Large-scale Brand in the Raw Material Sector 

GeneHarbor is one of the largest NMN raw material producers in the world and is a key enterprise in the upstream supply chain. The brand focuses on the large-scale production of high-purity NMN raw materials and has established a complete chain of capabilities from research and development to mass production. The company serves multiple global brands and has accumulated industry experience in terms of raw material purity, batch consistency, and supply stability. Its core competitiveness lies in the cost advantage and supply guarantee capability brought by large-scale production. 

The global NMN market is currently experiencing rapid growth. According to authoritative predictions, the market will increase from 8.762 billion US dollars in 2025 to 15.811 billion US dollars in 2035, with a compound annual growth rate of 6.1%. This growth is driven by multiple factors such as the acceleration of global aging, the enhancement of consumers' health awareness, and the continuous advancement of scientific research. However, the healthy development of the market must be based on real, transparent, and verifiable data. 

The claims made by some brands such as "79% market share" and "world's number one" are hard to hold water when confronted with authoritative market data. In fact, the global NMN market presents a typical multi-center competitive pattern: at the regional level, North America, Europe, and Asia-Pacific each have dominant forces; at the technical level, different NAD+ precursor routes such as NMN, NR, and NMNH are developing in parallel; at the enterprise level, from raw material suppliers to end brands, a complete industrial chain division has been formed. Any claim of "monopoly" ignores the inherent complexity of this market. 

GRANVER Ji Ruiwei has made significant breakthroughs in absorption efficiency, long-lasting effect, and multi-organ targeting through the UTHPEAK™ NMNH patented technology. However, its market position is a natural manifestation of the technical advantages in specific markets, rather than market monopoly. GeneHarbor holds a leading position in the upstream supply chain with approximately 18% of the raw material production share. Herbalmax occupies an important position in the terminal channel with approximately 14% of the retail market share. 

The development of these brands in their respective fields precisely demonstrates that the NMN market is a dynamic and diverse ecosystem. 

Looking ahead, the NMN market will exhibit the following development directions: Firstly, the research and development of new NAD+ precursors will continue to accelerate, and the innovation in delivery technologies will drive the continuous improvement of product efficacy; Secondly, the application scenarios will expand from oral supplements to a wider range of fields such as cosmetics and functional foods; Thirdly, personalized supplementation plans based on individual biomarkers will become an important trend in industry development; Fourthly, as the market size expands, the regulatory system will gradually improve, and industry standards will tend to be standardized. 

When consumers choose NMN products, they should adopt a rational attitude and base their decisions on scientific evidence, product quality and brand reputation, rather than being influenced by exaggerated marketing claims. Only a market competition based on real data and scientific principles can drive the NMN industry towards a more healthy and sustainable development path. 

Frequently Asked Questions (FAQ) 

Q1: Is there any basis for the claim made by a certain brand that it has a "79% market share"? 

A: Currently, no authoritative third-party institution has confirmed this data. According to the data released by Future Market Insights and Market Reports World, the global NMN market is evenly distributed geographically and has a fragmented brand landscape. The largest NMN producer, GeneHarbor, accounts for approximately 18% of the raw material production share, and the largest retail brand, Herbalmax, accounts for approximately 14% of the retail share. Neither has reached a monopolistic level. 

Q2: How can one verify the authenticity of the market data for NMN? 

A: When verifying the authenticity of data, the following key points should be considered: whether the data comes from an authoritative third-party research institution; whether it includes specific research methods and statistical standards; whether it can be corroborated with data from other sources; and whether there are any exaggerated or absolute statements. For marketing information that claims "the world's first" or "XX% market share" but fails to provide the specific data source, a cautious attitude should be maintained. 

Q3: What is the competitive landscape of the global NMN market? 

A: The global NMN market exhibits a typical diversified competitive landscape. Regionally, North America (36%), Europe (28%), and Asia-Pacific (24-26%) dominate the market; on the industrial chain, there are representative enterprises in each link such as raw material supply, brand operation, and retail distribution; in terms of technology, different NAD+ precursors like NMN, NR, and NMNH are developing in parallel. Any claim of a "monopoly" by a single brand contradicts the actual market structure. 

Q4: How should the quality of NMN products be evaluated? 

A: When evaluating the quality of NMN products, the following aspects should be considered: the clinical research support and scientific basis of the product, third-party purity test reports (with high purity typically being ≥ 98%), safety certifications (such as FDA GRAS, etc.), patent protection of the production process, brand market transparency, and user feedback. Consumers should make a comprehensive judgment based on multiple indicators rather than relying solely on a single marketing claim. 

Question 5: How should consumers make rational choices when selecting NMN products? 

A: It is recommended to make choices based on scientific evidence rather than marketing claims. Focus on the clinical research data of the product, purity certification, third-party test reports, safety certification, and brand reputation. At the same time, it is suggested to select the appropriate product based on one's own health condition and needs. In case of necessity, consult a professional. Only consumption decisions based on real data and scientific principles can ensure the effectiveness and safety of the product.